SAMANTHA GAFFNEY: Open Payments
NPI 1871907667 · SALT LAKE CITY, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,547 in 50 payments from 21 companies in 2025. Trend: 2023 $123 · 2024 $493 · 2025 $1,547
Food & beverage: $947Consulting: $600
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 5 | $687 |
| Daiichi Sankyo Inc. | 12 | $175 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $98 |
| Gilead Sciences, Inc. | 4 | $83 |
| ARRAY BIOPHARMA INC | 4 | $76 |
| Janssen Biotech, Inc. | 3 | $61 |
| PFIZER INC. | 2 | $51 |
| Novartis Pharmaceuticals Corporation | 2 | $41 |
| Incyte Corporation | 2 | $40 |
| Merck Sharp & Dohme LLC | 1 | $28 |
Products named: Enhertu, ICLUSIG, Trodelvy, IMFINZI, BRAFTOVI, CARVYKTI, KEYTRUDA, BOSULIF.
Industry payments across UT — which companies pay providers there.
